New project seeks to develop greener inhalers for treating asthma and COPD

Researchers are looking at ways to boost the performance and lower the environmental impact of millions of inhalers used for treating asthma and COPD. Working with Kindeva – a drug manufacturer based in Loughborough – the University is developing a new way to deliver medication to the lungs via an inhaler using greener propellants. Lead […]

COVID19's cytokine storm ushers in a local complement storm in the lungs

A new study published in the journal Science Immunology analyzed lung epithelial cells from patients infected with COVID-19 and found the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces the complement system as a dangerous weapon for viral infection. The complement system is an extension of the innate immune system to recognize pathogens and remove […]

New biomarker discovery could help guide treatment of active sarcoidosis

Low blood levels of immune cells called lymphocytes, in combination with higher levels of inflammation on PET/CT scans, are indicators of active sarcoidosis — an inflammatory disease that attacks multiple organs, particularly the lungs and lymph nodes — which disproportionately affects African Americans. The discovery by researchers at the University of Illinois Chicago could help […]

Rural hospital remains entrenched in Covid ‘war’ even amid vaccine rollout

Editor's note: KHN wrote about St. James Parish Hospital in April, when it was experiencing its first surge of Covid-19 patients. Ten months later, we checked in to see how the hospital and its staff were faring. The "heroes work here" sign in front of St. James Parish Hospital has been long gone, along with […]

Moxifloxacin APO

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MOXIFLOXACIN APO TABLETS Contains the active ingredient moxifloxacin (as hydrochloride monohydrate) Consumer Medicine Information   What is in this leaflet This leaflet answers some common questions about this medicine. It does not contain all the available information. It does not take the […]

Tobi

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TOBI® SOLUTION FOR INHALATION Solution for Inhalation tobramycin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about TOBI Solution for Inhalation (“TOBI”). It does not contain all the available information. It does not take the place […]

Alvesco

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ALVESCO® ciclesonide Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about ALVESCO. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information […]

Kalixocin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KALIXOCIN clarithromycin CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Kalixocin. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have […]